Cancer treatment remains a lottery as HAs fail to follow NICE guidelines

More than 20 per cent of health authorities are still not following national guidelines for the drug treatment of breast and ovarian cancer, according to a survey.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
  • 10 expert briefings every fortnight (Premium only)

Already a subscriber? Sign into your account here